Changes in prevalence, severity, and recovery in tardive dyskinesia with age.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Archives of General Psychiatry

• Publication date

  1980-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1980.01780250054006PMID 6108750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What is the best maintenance dose of neuroleptics in schizophrenia?

  1980cited by this paper
• Aging alters amphetamine-induced stereotyped gnawing and neostriatal elimination of amphetamine in mice.

  1980cited by this paper
• Behavioral and Biochemical Effects of Chronic Neuroleptic Drugs: Interaction with Age

  1980cited by this paper
• Spontaneous dyskinesias vs. neuroleptic-induced dyskinesias in 270 elderly subjects.

  1980cited by this paper
• Past History of Drug and Somatic Treatments in Tardive Dyskinesia

  1980cited by this paper
• Central neurotransmitters and aging.

  1980cited by this paper
• Neuroleptic Drugs and Other Factors Predisposing to Tardive Dyskinesia

  1980cited by this paper
• Cholinergic receptor loss in brains of aging mice.

  1980cited by this paper
• Low dose fluphenazine decanoate in maintenance treatment of schizophrenia.

  1979cited by this paper
• Biotransformation of drugs during aging.

  1979cited by this paper
• Factors related to tardive dyskinesia.

  1979cited by this paper
• A systematic investigation of tardive dyskinesia in inpatients.

  1979cited by this paper
• An assessment of tardive dyskinesia in schizophrenic outpatients

  1979cited by this paper
• Aging and monoamine receptors in brain.

  1979cited by this paper
• Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.

  1979cited by this paper
• Prevalence of tardive dyskinesia.

  1979cited by this paper
• Reversibility of Tardive Dyskinesia

  1979cited by this paper
• Prevalence of tardive dyskinesia.

  1979cited by this paper
• The tardive dyskinesia syndrome.

  1978cited by this paper
• Applied Nonparametric Statistics

  1978cited by this paper
• Tardive dyskinesia: Age and sex differences in hospitalized schizophrenics

  1978cited by this paper
• Withdrawal syndromes associated with antipsychotic drugs.

  1978cited by this paper
• Drug history and tardive dyskinesia.

  1978cited by this paper
• Tardive dyskinesia: characterization and prevalence in a statewide system.

  1978cited by this paper
• Tardive dyskinesia and psychotropic drug history

  1978cited by this paper
• Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.

  1977cited by this paper
• Aging and extrapyramidal function.

  1977cited by this paper
• SPONTANEOUS BUCCOLINGUOFACIAL DYSKINESIA IN THE ELDERLY

  1977cited by this paper
• Tardive Dyskinesia in Psychogeriatric Patients: A Five‐Year Follow‐Up

  1977cited by this paper
• Tardive dyskinesia: are first signs reversible?

  1977cited by this paper
• The pathophysiologic basis of tardive dyskinesia.

  1977cited by this paper
• A survey of tardive dyskinesia in psychiatric outpatients.

  1977cited by this paper
• Epidemiology of tardive dyskinesia: I.

  1976cited by this paper
• Some aspects of dopamine in the basal ganglia.

  1976cited by this paper
• Persistent dyskinesia after long-term treatment with neuroleptics in Japan: its present status and clinical problems.

  1976cited by this paper
• Tardive Dyskinesia: An Evaluation of the Etiologic Association with Neuroleptic Therapy

  1974cited by this paper
• Tardive and withdrawal dyskinesia associated with haloperidol.

  1974cited by this paper
• Factors predisposing to drug-induced neurologic effects.

  1974cited by this paper
• Catecholamine metabolism in the brains of ageing male mice.

  1973cited by this paper
• Neurological syndromes associated with antipsychotic drug use. A special report.

  1973cited by this paper
• Persistent Dyskinesia

  1973cited by this paper
• Tardive Dyskinesia: Its Relation to Neuroleptic and Antiparkinson Drugs

  1972cited by this paper
• The prevalence of tardive dyskinesias in mental hospital patients.

  1972cited by this paper
• A Study of Facial Dyskinesia in a Mental Hospital Population

  1971cited by this paper
• Extrapyramidal Disorders After Prolonged Phenothiazine Therapy

  1971cited by this paper
• Das klinische Wirkungsbild von Clozapin: (Untersuchung mit dem AMP-System)

  1971cited by this paper
• Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets.

  1971cited by this paper
• A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.

  1970cited by this paper
• Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.

  1968cited by this paper
• PHENOTHIAZINE‐INDUCED DYSKINESIA IN NURSING‐HOME PATIENTS *

  1968cited by this paper
• Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics.

  1967cited by this paper
• Persistent Oral Dyskinesia in Female Mental Hospital Patients

  1966cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMAGOTHERAPY OF PSYCHOSES

  1964cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

  1964cited by this paper
• A survey of drug-induced extrapyramidal reactions.

  1961cited by this paper

• The Prevalence of Tardive Dyskinesia In Patients With Schizophrenia Treated With Antipsychotics In Malaysia

  2025cites this paper
• Long-term thiethylperazine treatment in the Tg4-42 mouse model of Alzheimer's disease mouse: Therapeutic potential vs. adverse effects.

  2025cites this paper
• Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States

  2023cites this paper
• Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications

  2023influential citation
• Medical and Surgical Treatment for Medication‐Induced Tremor: Case Report and Systematic Review

  2022cites this paper
• Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review

  2022cites this paper
• Treatable Hyperkinetic Movement Disorders Not to Be Missed

  2021cites this paper
• Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project

  2021cites this paper
• Buspirone-associated Movement Disorder: A Literature Review.

  2020cites this paper
• Medication-Related Problems in Surgical Patients

  2020cites this paper
• Analysis of risk factors and outcomes in psychiatric inpatients with tardive dyskinesia: A nationwide case-control study

  2019cites this paper
• Tardive Dyskinesia

  2019cites this paper
• Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly

  2018cites this paper
• Vesicular monoamine transporter inhibitors versus placebo for antipsychotic‐induced tardive dyskinesia

  2018cites this paper
• Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.

  2018cites this paper
• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

  2018cites this paper
• Anticholinergic medication for antipsychotic-induced tardive dyskinesia.

  2018cites this paper
• Historical perspectives on tardive dyskinesia.

  2018cites this paper
• Cholinergic medication for antipsychotic-induced tardive dyskinesia

  2018cites this paper
• Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

  2018cites this paper
• An Underrecognized Phenomenon

  2017cites this paper
• Tardive Dyskinesia: 21st Century May Bring New Treatments to a Forgotten Disorder

  2017cites this paper
• Extrapyramidal Symptoms II (Dystonia, Akathisia, Tardive Dyskinesia)

  2017cites this paper
• Tardive Dyskinesia in Long Term Hospitalized Patients with Schizophrenia

  2016cites this paper
• Therapeutic advances in Huntington’s disease

  2016cites this paper
• The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk

  2016cites this paper
• Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics

  2016cites this paper
• Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.

  2015cites this paper
• Antipsychotics-Induced Tardive Syndrome: A Retrospective Epidemiological Study

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic

  2014cites this paper
• Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?

  2014influential citation
• Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.

  2014cites this paper
• Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder

  2013cites this paper
• Tardive and spontaneous dyskinesia incidence in the general population

  2013cites this paper
• Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia (Protocol)

  2013cites this paper
• Basal ganglia disorders

  2013cites this paper
• Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.

  2012cites this paper
• No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients

  2012cites this paper
• Drug Usage in Surgical Patients: Preventing Medication-Related Problems

  2011cites this paper
• Medication Usage in Older Cardiothoracic Surgical Patients

  2011cites this paper
• Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.

  2011cites this paper
• Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

  2011cites this paper
• Behavioral pharmacology of orofacial movement disorders.

  2011cites this paper
• Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia

  2011cites this paper
• Neurological Complications of Antipsychotic Drugs

  2011cites this paper
• The tardive syndromes

  2011cites this paper
• The prevalence of tardive dyskinesia in Chinese Singaporean patients with schizophrenia: revisited.

  2010cites this paper
• Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report.

  2010cites this paper
• Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia: Thirty-Six-Month Results From the European Schizophrenia Outpatient Health Outcomes Study

  2010cites this paper
• Geriatric psychopharmacology: evolution of a discipline.

  2010cites this paper
• Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial

  2009cites this paper
• Tardive dyskinesia with ziprasidone and citalopram use in an elderly female patient

  2008cites this paper
• Gene Association Studies of Schizophrenia and Tardive Dyskinesia

  2008cites this paper
• Antipsychotic-induced extrapyramidal symptoms and their management

  2008cites this paper
• [Late dyskinesias. Clinical aspects, pathophysiology, therapy].

  2008cites this paper
• Tardive dyskinesia and glucid metabolism

  2007cites this paper
• Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

  2007cites this paper
• Drug-induced tardive motor syndromes.

  2007cites this paper
• Tetrabenazine in the treatment of Huntington’s disease

  2007cites this paper
• Assessment of neuroleptic-induced movement disorders in a naturalistic schizophrenia population

  2006cites this paper
• Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?

  2006cites this paper
• Tardive dyskinesia in geriatric patients

  2006cites this paper
• Polekowe zaburzenia ruchowe

  2006cites this paper
• Focus on lower risk of tardive dyskinesia with atypical antipsychotics.

  2006cites this paper
• Nonparkinsonism movement disorders in the elderly.

  2006cites this paper
• Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.

  2006cites this paper
• Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics

  2005cites this paper
• Neuroleptic-induced movement disorders: an overview.

  2005cites this paper
• Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.

  2005influential citation
• Tardive dyskinesia in non-western countries: A review

  2005cites this paper
• On the pathogenesis of abnormal involuntary movements in lithium-treated patients with major affective disorder

  2005cites this paper
• Antipsychotic Medications and Drug‐Induced Movement Disorders Other Than Parkinsonism: A Population‐Based Cohort Study in Older Adults

  2005cites this paper
• Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

  2005cites this paper
• Neuroleptic‐Induced Movement Disorders: Deconstructing Extrapyramidal Symptoms

  2004cites this paper
• Levodopa and receptor sensitivity modification in tardive dyskinesia

  2004cites this paper
• Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.

  2004cites this paper
• Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride.

  2004cites this paper
• Effects of maturation and aging on behavioral responses to haloperidol in the rat

  2004cites this paper
• Prevalence of abnormal involuntary movements (“spontaneous dyskinesias”) in the normal elderly

  2004cites this paper
• Clinical Features And Management Of Classic Tardive Dyskinesia, Tardive Myoclonus, Tardive Tremor, And Tardive Tourettism

  2004cites this paper
• Ethnicity and the Course of Tardive Dyskinesia in Outpatients Presenting to the Motor Disorders Clinic at the Maryland Psychiatric Research Center

  2004cites this paper
• Anaesthesia in Elderly Patients with Neurodegenerative Disorders

  2004cites this paper
• The Epidemiology Of Tardive Dyskinesia

  2004cites this paper
• CYP2D6 Polymorphism and Tardive Dyskinesia in Schizophrenic Patients

  2003cites this paper
• CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.

  2003cites this paper
• SUCCESSFUL THERAPY OF TARDIVE DYSKINESIA IN A 71‐YEAR‐OLD WOMAN WITH A COMBINATION OF TETRABENAZINE, OLANZAPINE AND TIAPRIDE

  2003cites this paper
• Tardive dyskinesia in elderly patients: an update.

  2003cites this paper
• Pharmakotherapie: Besonderheiten bei älteren Patienten

  2003cites this paper
• Pharmacogenomics in schizophrenia: the quest for individualized therapy.

  2002cites this paper
• Tardive dyskinesia in elderly patients: an update.

  2002cites this paper
• Tardive Dyskinesia in the Elderly: Data From a Prospective Study

  2002cites this paper
• Tardive dyskinesia and impaired glucose tolerance

  2002cites this paper
• Treatment of bipolar disorder in older adults

  2002cites this paper
• Effects of Newer Antipsychotics on Extrapyramidal Function

  2002cites this paper
• Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia

  2002cites this paper
• Women and Drugs: A New Era for Research, 65

  2002cites this paper
• Tardive dyskinesia.

  2002cites this paper
• Pharmacogenetics of Tardive Dyskinesia: Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism

  2002cites this paper
• Tardive Dyskinesia Among Chinese and Malay Patients With Schizophrenia

  2002cites this paper